EUVIMEDObjevte EUVIMED
Crossref

Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation

Li Liu, Ying Zhou, Xiao Huang, Hefen Chen, Zhujun Gong, Jing Zhang, Fang Zeng, Hong Zhou, Yu Zhang iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15237 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Li Liu and 8 co-authors. Institution: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Major MEDLINE topics: Kidney Transplantation, Heart Transplantation, Drugs, Chinese Herbal. Cited 1 times so far (Crossref); 40 references. Funded by: National Key Research and Development Program, National Natural Science Foundation of China, National Basic Research Program of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Aim

Wuzhi preparations (WZP) are commonly administrated with tacrolimus (TAC) in China to improve the liver function and increase the exposure of TAC. This study aims to investigate the effects of WZP on TAC in pediatric heart transplantation (HTx) patients carrying the CYP3A5*1 allele during the early period after transplantation and also make a comparison with these effects in adult recipients.

Methods

A total of 81 recipients with CYP3A5*1 allele were included and divided into the pediatric group ( n = 29) and adult group ( n = 52). The changes in TAC dose‐corrected trough blood concentrations (C 0 /D), dose requirement as well as intra‐patient variability(IPV) of C 0 /D after co‐therapy with WZP were evaluated.

Results

The TAC C 0 /D was significantly increased 1.7 and 1.8 times after co‐administration of WZP in the pediatric and adult groups, respectively. We further analyzed the pediatric patients, found that no statistical difference was observed in TAC C 0 /D before and after co‐therapy with WZP in children

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationHeart TransplantationDrugs, Chinese HerbalAdultHumansChildTacrolimusImmunosuppressive AgentsAllelesCytochrome P-450 CYP3AGenotypePolymorphism, Single Nucleotide

Author keywords

CYP3A5 expressersWuzhi preparationageheart transplantationtacrolimus

Substances

TacrolimusImmunosuppressive AgentswuzhiCytochrome P-450 CYP3ACYP3A5 protein, humanDrugs, Chinese Herbal

Authors and institutions

  • Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.
  • Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID profiles: Yu Zhang

Funding

  • National Key Research and Development Program
  • National Natural Science Foundation of China
  • National Basic Research Program of China

Cite

APA

Liu, L., Zhou, Y., Huang, X., Chen, H., Gong, Z., Zhang, J., Zeng, F., Zhou, H., & Zhang, Y. (2024). Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15237

Vancouver

Liu L, Zhou Y, Huang X, Chen H, Gong Z, Zhang J, et al. Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15237

BibTeX
@article{Liu2024,
  author = {Liu, Li and Zhou, Ying and Huang, Xiao and Chen, Hefen and Gong, Zhujun and Zhang, Jing and Zeng, Fang and Zhou, Hong and Zhang, Yu},
  title = {Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15237}
}
Start for free →